Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Denny

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
BMC Medical Informatics and Decision Making|November 20, 2020
Comparison of deep learning with regression analysis in creating predictive models for SARS-CoV-2 outcomesAhmed Abdulaal, Aatish Patel, Esmita Charani, et al.
BMC Infectious Diseases|June 12, 2021
Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysisSarah Denny, Timothy M Rawson, Peter Hart, et al.
The Journal of Infection|February 21, 2021
A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic waveSarah Denny, Alireza Abdolrasouli, Tamador Elamin, et al.
Cell Cycle (Georgetown, Tex.)|December 11, 2008
Transient treatment with CDK inhibitors eliminates proliferative potential even when their abilities to evoke apoptosis and DNA damage are blockedSimon F Scrace, Peter Kierstan, Jenifer Borgognoni, et al.
Communications Medicine|June 16, 2023
Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisationScott J C Pallett, Joseph Heskin, Fergus Keating, et al.
Journal of Medicinal Chemistry|December 17, 2008
Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidinesRoger J Gillespie, Samantha J Bamford, Ruth Botting, et al.
Thorax|February 5, 2026
Understanding risk of poor outcomes in adults hospitalised with respiratory syncytial virus infection: evidence from a multicentre UK cohortTommaso Morelli, Martha Purcell, Jon Panaguiton, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
BMC Medical Informatics and Decision Making|November 20, 2020
Comparison of deep learning with regression analysis in creating predictive models for SARS-CoV-2 outcomesAhmed Abdulaal, Aatish Patel, Esmita Charani, et al.
BMC Infectious Diseases|June 12, 2021
Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysisSarah Denny, Timothy M Rawson, Peter Hart, et al.
The Journal of Infection|February 21, 2021
A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic waveSarah Denny, Alireza Abdolrasouli, Tamador Elamin, et al.
Cell Cycle (Georgetown, Tex.)|December 11, 2008
Transient treatment with CDK inhibitors eliminates proliferative potential even when their abilities to evoke apoptosis and DNA damage are blockedSimon F Scrace, Peter Kierstan, Jenifer Borgognoni, et al.
Communications Medicine|June 16, 2023
Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisationScott J C Pallett, Joseph Heskin, Fergus Keating, et al.
Journal of Medicinal Chemistry|December 17, 2008
Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidinesRoger J Gillespie, Samantha J Bamford, Ruth Botting, et al.
Thorax|February 5, 2026
Understanding risk of poor outcomes in adults hospitalised with respiratory syncytial virus infection: evidence from a multicentre UK cohortTommaso Morelli, Martha Purcell, Jon Panaguiton, et al.
Pageof 2